Immunogenicity and Reactogenicity of 1 versus 2 Doses of Trivalent Inactivated Influenza Vaccine in Vaccine‐Naive 5–8‐Year‐Old Children

2006190 citationsJournal Articlebronze Open Access

Authors

Kathleen M. Neuzil · Program for Appropriate Technology in Health

Lisa A. Jackson · Center for Clinical Studies

Jennifer C. Nelson · Center for Clinical Studies

Alexander Klimov · National Influenza Center

Nancy J. Cox · National Influenza Center

Carolyn B. Bridges · National Center for Immunization and Respiratory Diseases

John Dunn

Abstract

The present study supports the need for 2 doses of TIV in 5-8-year-olds receiving TIV for the first time. Efforts to increase compliance with the 2-dose recommendation are warranted.

Topics & Keywords

Influenza Virus Research Studies Bacterial Infections and Vaccines Respiratory viral infections research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Infectious Diseases

Volume 194, Issue 8, pp. 1032-1039

DOI: 10.1086/507309

Field-Weighted Citation Impact: 7.67